ORALLY BIOAVAILABLE PRODRUGS OF EDARAVONE WITH ALTERED PHARMACOKINETIC PROPERTIES AND METHODS OF USE THEREOF

摘要

The invention generally relates to orally bioavailable prodrugs of Edaravone (including analogs, derivatives, and salts thereof) with altered pharmacokinetic properties and methods of use thereof.